Clinical Trial Update: Ocular Allergy Treatment Practical Impact Trial [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update for an ocular allergy treatment affecting allergic conjunctivitis and rhinoconjunctivitis; the trial status is currently unknown…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Allergic Conjunctivitis
• Rhinoconjunctivitis

Snippet

Sponsor: Starx Research Center, LLC | Conditions: Allergic Conjunctivitis, Rhinoconjunctivitis | Phase 4 | Status: UNKNOWN